Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Radioiodine Therapy for Hyperthyroidism
source: The New England Journal of Medicine
year: 2011
authors: Douglas S. Ross
summary/abstract:A 37-year-old woman receives a diagnosis of Graves’ disease and is treated with methimazole for 1 year. After completing this treatment, she presents with recurrent symptoms of hyperthyroidism. Radioiodine ablation is recommended.
organization: Massachusetts General Hospital, USADOI: 10.1056/NEJMct1007101
read more full text
myBinderRelated Content
-
Lugol’s Solution and Other Iodide Preparations: Perspectives and Research Directions in Graves’ DiseaseLugol's solution and other preparations ...
-
Hyperthyroidism Figurehttps://www.uptodate.com/contents/image?...
-
Hyperthyroid Patients Without Graves’ Orbitopathy are not at Increased Risk of Developing Glaucoma: A Nationwi...Purpose: Graves' disease (GD) and toxic...
-
Back on Track: 3 Time Olympic Gold Medalist Gail Devers’ StoryBlink and you just might miss the fastes...
-
Reversible Pulmonary Hypertension and Clinical Right Heart Failure Associated With Graves’ DiseaseBackground: Heart failure is typically ...
-
Relation Between Therapy for Hyperthyroidism and the Course of Graves’ OphthalmopathyBackground: The chief clinical characte...
-
Management of Neonates Born to Women With Graves’ Disease: A Cohort StudyObjective: Hyperthyroidism in neonates ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google